Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 1,101–1,200 of 1,647
Gooley, J. L., Walters, J. M., & Ward, G. M. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0018 · Cited by 6
Woolcott, O. O., Richey, J. M., Kabir, M., Chow, R. H.-P., Iyer, M. S., Kirkman, E. L., Stefanovski, D., Lottati, M., Kim, S. P., Harrison, L. N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123558 · Cited by 6
Self-citationPerformance monitoring of diabetic patient systems
Owens, C., & Doyle, F. (2005) · Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2001.1020635 · Cited by 6
Maleki, A., & Geramipour, A. (2011) · International Conference on Control, Instrumentation, and Automation · doi:10.1109/icciautom.2011.6356642 · Cited by 8
Daud, N. A. M., Mahmud, F., & Jabbar, M. H. (2015) · Cited by 5
Deng, L., Liu, S., Gong, Y., Tian, H., Liu, Y., Song, J., Ran, X., Yu, H., Zhang, X., Long, Y., et al. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0002 · Cited by 7
Gonzalez, A. A., Voos, H., & Darouach, M. (2016) · IEEE-EMBS Conference on Biomedical Engineering and Sciences · doi:10.1109/iecbes.2016.7843479 · Cited by 7
Personal Health Systems for Diabetes Management, Early Diagnosis and Prevention
Zarkogianni, K., & Nikita, K. S. (2015) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-4666-8828-5.ch022 · Cited by 13
Su, H., Ma, X., Shen, Y., He, X., Ying, L., Zhu, W., Wang, Y., Bao, Y., & Zhou, J. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01452-0 · Cited by 6
CarbMetSim: A discrete-event simulator for carbohydrate metabolism in humans
Goyal, M., Aydas, B., Ghazaleh, H., & Rajasekharan, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0209725 · Cited by 6
Mather, K. J., Chen, M. E., & Hannon, T. S. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107589 · Cited by 6
Multiple model adaptive postprandial glucose control of type 1 diabetes
Raafat, S. M., Amear, B. K. A.-A., & Al‐Khazraji, A. (2021) · Engineering Science and Technology an International Journal · doi:10.1016/j.jestch.2020.11.007 · Cited by 6
Global Sensitivity Analysis on the Bergman Minimal Model
Nandi, S., & Singh, T. (2020) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2020.12.431 · Cited by 6
Quasi-Model-Based Control of Type 1 Diabetes Mellitus
György, A., Kovács, L., Szalay, P., Drexler, D. A., Benyó, B. I., & Benyó, Z. (2011) · Journal of Electrical and Computer Engineering · doi:10.1155/2011/728540 · Cited by 6
Lin, R., Ju, H., Yuan, Z., Zeng, L., Sun, Y., Su, Z., Yang, Y., Wang, Y., & Li, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03518-x · Cited by 6
Murata, M., Adachi, H., Oshima, S., & Kurabayashi, M. (2018) · International Heart Journal · doi:10.1536/ihj.17-245 · Cited by 6
Wilinska, M. E., & Hovorka, R. (2014) · Lecture notes in bioengineering · doi:10.1007/978-3-642-54464-4_6 · Cited by 8
Analyzing a novel model of human blood glucose system at molecular levels
Kovács, L., György, A., Almássy, Z., & Benyó, Z. (2009) · European Control Conference (ECC) · doi:10.23919/ecc.2009.7074780 · Cited by 6
Model based validation of meal inputs in diabetes therapy
Estrada, G. C., Kirchsteiger, H., del Re, L., & Renard, É. (2009) · IFAC Proceedings Volumes · doi:10.3182/20090706-3-fr-2004.00040 · Cited by 6
Ruggeri, A., & Cobelli, C. (1988) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)57544-8 · Cited by 6
Self-citationSimplified Mathematical Model of Glucose-Insulin System
Ntaganda, J. M., Minani, F., Banzi, W., Mpinganzima, L., Niyobuhungiro, J., Gahutu, J. B., Rutaganda, E., Kambutse, I., & Dusabejambo, V. (2018) · American Journal of Computational Mathematics · doi:10.4236/ajcm.2018.83019 · Cited by 6
Polynomial model inversion control: numerical tests and applicationsPreprint
Novara, C. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1509.01421 · Cited by 7
Insulin and Hypoglycemic Agents
Sleevi, M. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc057 · Cited by 7
Signals adapting the beta cells to changes in insulin sensitivity
Åhrén, B., & Pacini, G. (2003) · International Congress Series · doi:10.1016/s0531-5131(02)01281-5 · Cited by 6
Benfluorex and blood glucose control in non insulin-dependent diabetic patients
Cavallo‐Perin, P., Estivi, P., Boine, L., Galletti, R., Pacini, G., Cobelli, C., & Pagano, G. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03350279 · Cited by 6
Self-citationTobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 7
A Robust Approach to Control Blood Glucose Level: Diabetes Mellitus Type I
Ruiz-Velazquez, E., Campos-Delgado, D. U., & Femat, R. (2003) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)35667-7 · Cited by 6
Quantification of beta cell carrying capacity in prediabetesPreprint
Woller, A., Tamir, Y., Bar, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.31.578144 · Cited by 6
Prendin, F., Streicher, O., Cappon, G., Rolfes, E., Herzig, D., Bally, L., & Facchinetti, A. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02856-5 · Cited by 7
de Hoogh, I. M., Snel, T., Kamstra, R. J. M., Krone, T., de Graaf, A. A., & Pijl, H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16654 · Cited by 5
Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes
Vazquez, L., Arreola, E. V., NAGUL, M., Krakoff, J. A., & Hanson, R. L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag101 · Cited by 8
Leahy, J. L., & Pratley, R. E. (2011) · Translational endocrinology & metabolism · doi:10.1210/team.9781879225824.ch1 · Cited by 9
Choi, J., Kim, J., & Oh, H. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323329 · Cited by 11
A novel automated fuzzy model for diabetes mellitus
Abadi, D. N. M., Khooban, M. H., & Siahi, M. (2011) · International Conference on Control, Instrumentation, and Automation · doi:10.1109/icciautom.2011.6356682 · Cited by 5
Omar, B. A., Pacini, G., & Åhrén, B. (2014) · Physiological Reports · doi:10.14814/phy2.12011 · Cited by 5
Ganji, M., & Pourgholi, M. (2020) · Iranian Conference on Electrical Engineering · doi:10.1109/icee50131.2020.9260768 · Cited by 5
Ligon, C., Shah, A. M., PRASAD, M. A., & Laferrère, B. (2021) · Diabetes Care · doi:10.2337/dc21-0395 · Cited by 6
Association between hyperlipidemia and calcium oxalate lower urinary tract uroliths in dogs
Paulin, M. V., Dunn, M. E., Vachon, C., Beauchamp, G., & Conversy, B. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16324 · Cited by 9
Brown, M., & Matveyenko, A. V. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.842603 · Cited by 10
Leptin effect’s on glucose and insulin kinetics: A mathematical model
Maamar, M. H., & Belhamiti, O. (2022) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2022.106591 · Cited by 6
Data-driven nonlinear system identification of blood glucose behaviour in Type I diabetics
Santhakumaran, S., & Shardt, Y. A. W. (2022) · Control Engineering Practice · doi:10.1016/j.conengprac.2022.105405 · Cited by 6
Xing, Y., Ye, H., Zhang, X., Cao, W., Zheng, S., Bian, J., & Guo, Y. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995522 · Cited by 5
A novel IVGTT model including interstitial insulin
Jin, J., Li, J., Xu, R., Yu, L., & Jin, Z. (2023) · Mathematics in Applied Sciences and Engineering · doi:10.5206/mase/15505 · Cited by 6
VISENTIN, R., Brodersen, K., Richelsen, B., Møller, N., Man, C. D., Pedersen, A. K., Abrahamsen, J., Holst, J. J., & Nielsen, M. F. (2023) · Journal of Diabetes Research · doi:10.1155/2023/7127426 · Cited by 6
New Principles and Adequate Robust Control Methods for Artificial Pancreas
Kovács, L., Benyó, Z., Kovács, A., & Benyó, B. I. (2010) · Studies in computational intelligence · doi:10.1007/978-3-642-15220-7_7 · Cited by 5
Growth patterns during childhood and the relationship with acylation‐stimulating protein
Leunissen, R. W. J., Gao, Y., Cianflone, K., Stijnen, T., & Hokken‐Koelega, A. C. S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03771.x · Cited by 6
Sato, Y., Oka, R., Nakasone, Y., Katakura, M., Yamauchi, K., & Aizawa, T. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0122 · Cited by 5
The impact of family history of type 2 diabetes on pancreatic β-cell function
Wang, Z., Zhang, S., Gong, L., Ren, W., Li, R., Rui-zhi, Z., Zhang, Y., Wang, M., & Li, Q. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.004 · Cited by 7
Minimal models of glucose/insulin dynamics in the intact organism
Bergman, R. N., Cobellit, C., & TOFFOLO, G. M. (1981) · Transactions of the Institute of Measurement and Control · doi:10.1177/014233128100300404 · Cited by 5
Self-citationInvestigating the Applicability of qALPV Modeling to ICU Models for Glycaemic Control
Kovács, L., Szalay, P., György, A., Benyó, Z., Chase, J. G., Benyó, B. I., & Hann, C. E. (2010) · UKACC International Conference on Control · doi:10.1049/ic.2010.0346 · Cited by 5
Optimal Tight Glycaemic Control Supported by Differential Geometric Methods
Kovács, L., Szalay, P., Benyó, B. I., et al. (2011) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-642-23508-5_91 · Cited by 5
How should we interpret retrospective blood glucose measurements? Sampling and Interpolation
Stewart, K. W., Thomas, F., Pretty, C. G., Chase, J. G., & Shaw, G. M. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.266 · Cited by 5
Effects of maternal and fetal LEP common variants on maternal glycemic traits in pregnancy
Lin, R., Ju, H., Yuan, Z., Zhang, C., Zeng, L., Sun, Y., Su, Z., & Li, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-18117-z · Cited by 5
Artificial pancreas: glycemic control strategies for avoiding hypoglycemia
Sereno, J. E., Caicedo, M. A., & Rivadeneira, P. S. (2018) · DYNA · doi:10.15446/dyna.v85n207.71535 · Cited by 6
Eberle, C., & Ament, C. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000471 · Cited by 5
Blood Glucose Regulation in Patients with Type 1 Diabetes Mellitus: A Robust MRAC Approach
Franco, R., Ríos, H., de Loza, A. F., et al. (2021) · Proceedings of the IEEE Conference on Decision & Control, including the Symposium on Adaptive Processes · doi:10.1109/cdc45484.2021.9683408 · Cited by 5
Diabetes Mellitus Complicating Pregnancy
Landon, M. B., Catalano, P. M., & Gabbe, S. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00040-8 · Cited by 7
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-2 · Cited by 5
Electrical and Computer Technology for Effective Diabetes Management and Treatment
Sandham, W. A., Lehmann, E. D., Zequera, M. L., Hamilton, D. J., Tatti, P., & Walsh, J. S. A. (2011) · Journal of Electrical and Computer Engineering · doi:10.1155/2011/289359 · Cited by 5
Markov jump modelling and control of stress effects on the blood glucose regulation system
Zohrabi, N., Momeni, H., & Zakeri, H. (2012) · Iranian Conference on Electrical Engineering · doi:10.1109/iraniancee.2012.6292496 · Cited by 5
Konrad, T., Golling, M. T., Vicini, P., et al. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02102-9 · Cited by 5
Self-citationKonrad, T., Markus, B. H., Allers, C., Vicini, P., TOFFOLO, G. M., Lakos, C., Viehmann, K., Hanisch, E. W., Encke, A., Cobelli, C., et al. (2001) · Transplant International · doi:10.1007/s001470050735 · Cited by 5
Self-citationModulation of Zn‐induced hyperinsulinemia/insulin resistance in Wistar rat fed modified poultry eggΨ
Taneja, S. K., & Mandal, R. (2009) · BioFactors · doi:10.1002/biof.51 · Cited by 5
Nguyen, H. T., Nguyen, D.-K., Shannon, A. G., & Owens, D. (2002) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.1997.758778 · Cited by 5
Holness, M. J., Greenwood, G. K., Smith, N. D., & Sugden, M. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1953-6 · Cited by 5
Martin, I. K., Christopher, M., ALFORD, F. P., & Best, J. D. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e148 · Cited by 5
Fabietti, P. G., Calabrese, G., Iorio, M., et al. (2001) · The International Journal of Artificial Organs · doi:10.1177/039139880102401006 · Cited by 5
Identification of Endocrine-Metabolic and Pharmacokinetic Systems
Cobelli, C. (1985) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)60539-1 · Cited by 7
Self-citationModel Based Control for Drug Delivery Systems
Dua, P., Dua, V., & Pistikopoulos, E. N. (2008) · Encyclopedia of Optimization · doi:10.1007/978-0-387-74759-0_397 · Cited by 5
Best Use of Models to Advance the Artificial Pancreas
Steil, G. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0420 · Cited by 5
A Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth With Obesity
Ha, J., Kim, J. Y., Springer, M., Chhabra, A., Chung, S. T., Sumner, A. E., Sherman, A., & Arslanian, S. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae582 · Cited by 4
Markoska, A., Mendoza, L. C., Valaiyapathi, R., Thorn, C., & Dornhorst, A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020029 · Cited by 4
Kumaran, K., Joshi, S. M., Gravio, C. D., Lubree, H., Joglekar, C. V., Bhat, D., Kinare, A. S., Bavdekar, A., Bhave, S. A., Pandit, A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-036897 · Cited by 4
Bergman, R. N. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176738 · Cited by 4
Self-citation(2024) · International journal of intelligent engineering and systems · doi:10.22266/ijies2024.0630.21 · Cited by 4
An LMI-Based Robust Fuzzy Controller for Blood Glucose Regulation in Type 1 Diabetes
Ganji, M., & Pourgholi, M. (2024) · doi:10.1109/icee63041.2024.10668193 · Cited by 4
Li, P., Yu, L., Guo, L., Dong, J., Hu, J., & Fang, Q. (2012) · World Congress on Intelligent Control and Automation · doi:10.1109/wcica.2012.6359435 · Cited by 4
Model-Based Sensor-Augmented Pump Therapy
Grosman, B., Voskanyan, G. R., Loutseiko, M., Roy, A., Mehta, A., Kurtz, N., Parikh, N., KAUFMAN, F. R., Mastrototaro, J. J., & Keenan, D. B. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700224 · Cited by 5
Simulation study on automatic blood glucose control
Chee, F., Fernando, T. L., & van Heerden, P. V. (2001) · doi:10.1109/anziis.2001.974116 · Cited by 4
A phenomenological model of plasma FFA, glucose, and insulin concentrations during rest and exercise
Roy, A., & Parker, R. S. (2010) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2010.5530687 · Cited by 6
Ding, L., Hou, X., Ma, X., Zong, W., Lu, H., Xiang, K., & Jia, W. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821f5eff · Cited by 4
Liu, W. (2012) · Modeling, simulation & applications · doi:10.1007/978-88-470-2490-8_4 · Cited by 5
An Automatic Insulin Infusion System based on H-Infinity Control Technique
Yasini, S., Karimpour, A., Sistani, M. B. N., & Ghareh, S. (2008) · Cairo International Biomedical Engineering Conference · doi:10.1109/cibec.2008.4786074 · Cited by 4
Identification of parameters of the glucose-insulin homeostasis under everyday live conditions
Tolks, C., & Ament, C. (2017) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi.2017.7897210 · Cited by 4
Tolks, C., & Ament, C. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.2576 · Cited by 4
Adams, C., & Lasseigne, D. G. (2018) · Letters in Biomathematics · doi:10.1080/23737867.2018.1429332 · Cited by 12
Feasibility of Fully Closed Loop Insulin Delivery in Type 2 Diabetes
ORNETZEDER, C., Reiterer, F., Christensen, M. B., Nørgaard, K., Freckmann, G., & del Re, L. (2019) · IEEE Conference on Control Technology and Applications (CCTA) · doi:10.1109/ccta.2019.8920591 · Cited by 5
An OGI model for personalized estimation of glucose and insulin concentration in plasma
Wang, W., Wang, S., Geng, Y., Qiao, Y., & Wu, T. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021420 · Cited by 5
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100132 · Cited by 4
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101278 · Cited by 6
Methods for Quantifying Insulin Sensitivity and Determining Insulin Time-Action Profiles
Krentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_1 · Cited by 6
Birjandi, S. Z., Sani, S. K. H., & Pariz, N. (2022) · Transactions of the Institute of Measurement and Control · doi:10.1177/01423312221119601 · Cited by 4
Campetelli, G., Lupo, M., Fina, B. L., Zumoffen, D., BASUALDO, M. S., & Rigalli, A. (2010) · IFAC Proceedings Volumes · doi:10.3182/20100707-3-be-2012.0097 · Cited by 4
Wu, S., & Furutani, E. (2016) · Transactions of the Institute of Systems Control and Information Engineers · doi:10.5687/iscie.29.258 · Cited by 4
Systems Pharmacology Modeling in Type 2 Diabetes Mellitus
Bosley, J., Maurer, T. S., & Musante, C. J. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_20 · Cited by 4
Methods to Assess In Vivo Insulin Sensitivity and Insulin Secretion
Bonadonna, R. C., Boselli, L., Dei, A., & Trombetta, M. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_11-1 · Cited by 9
Shestakova, E. A., Sklyanik, I. A., Сергеевна, П. А., & Shestakova, M. V. (2018) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1027 · Cited by 4
Takeuchi, M., Wu, B., Honda, M., Tsuboi, A., Kitaoka, K., Minato, S., Kurata, M., Kazumi, T., & Fukuo, K. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001244 · Cited by 4
Prediction Performance Comparison between three Intensive Care Unit Glucose Models
Herpe, T. V., Haverbeke, N., den Berghe, G. V., & Moor, B. D. (2009) · IFAC Proceedings Volumes · doi:10.3182/20090812-3-dk-2006.0096 · Cited by 4
Dietary fatty acids and insulin secretion
Mingrone, G. (2006) · Scandinavian Journal of Food & Nutrition · doi:10.1080/17482970601076354 · Cited by 6
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.